Inventor · disambiguated record
Andrew Lake
Also filed as: LAKE ANDREW C · Lake Andrew
11 granted patents·9 pending applications·36 citations·filing 2006–2025
87Inventor score
Files withSURFACE ONCOLOGY INC8ERASMUS UNIV MEDICAL CENTER4NOVARTIS AG3SURFACE ONCOLOGY LLC2VACCINEX INC2
Top patents by PatentIndex Score
20 records- 0192US9803016B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2017·Granted Oct 31, 2017·11 cites·30 claims
- 0291US11859000B2Anti-CCR8 antibodies and uses thereofVACCINEX INC·Filed 2021·Granted Jan 2, 2024·3 cites·20 claims
- 0391US11312783B2Antibody molecules to CD73 and uses thereofNOVARTIS AG·Filed 2018·Granted Apr 26, 2022·10 cites·26 claims
- 0488US10793637B2Antibodies that bind CD39 and uses thereofSURFACE ONCOLOGY INC·Filed 2020·Granted Oct 6, 2020·2 cites·20 claims
- 0587US10570201B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2017·Granted Feb 25, 2020·5 cites·39 claims
- 0685US10738128B2Antibodies that bind CD39 and uses thereofSURFACE ONCOLOGY INC·Filed 2019·Granted Aug 11, 2020·2 cites·19 claims
- 0783US11332524B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2019·Granted May 17, 2022·2 cites·19 claims
- 0882US12496342B2Anti-CCR8 antibodies and uses thereofVACCINEX INC·Filed 2023·Granted Dec 16, 2025·0 cites·33 claims
- 0979US11655303B2Anti-CD39 antibody compositions and methodsSURFACE ONCOLOGY INC·Filed 2020·Granted May 23, 2023·1 cites·19 claims
- 1068US2020291114A1Anti-cd47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2020·Application pending·0 cites
- 1168US2023039109A1Antibody molecules to cd73 and uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1267US2023042258A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1366US2020399394A1Antibodies That Bind CD39 and Uses ThereofSURFACE ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1462US10442858B2Anti-CD47 antibodies and methods of useERASMUS UNIV MEDICAL CENTER·Filed 2017·Granted Oct 15, 2019·0 cites·76 claims
- 1560US2025154244A1Anti-il-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2025·Application pending·0 cites
- 1659US12358978B2Anti-IL-27 antibodies and uses thereofSURFACE ONCOLOGY LLC·Filed 2019·Granted Jul 15, 2025·0 cites·17 claims
- 1755US2022389115A1Methods of Treating Cancer with an Anti-CD39 AntibodySURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1854US2023036592A1Methods of treating cancer with an anti-cd39 antibody and pembrolizumabSURFACE ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1944US2021214459A1Antibody molecules to cd73 and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2037US2007014776A1Identification of adiponutrin-related proteins as esterases and methods of use for the sameGIMENO RUTH E·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Lake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →